NATERA, INC. Cost of Goods Sold (Deprecated 2018-01-31)
NATERA, INC. (NTRA) reported Cost of Goods Sold (Deprecated 2018-01-31) of $39.20 million for the 3-month period ending 2018-06-30, per its 10-Q filed 2018-08-09.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsSold · last filed 2018-08-09
- NATERA, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2018-06-30 was $39.20M, a 16.30% increase year-over-year.
- NATERA, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $39.05M, a 18.03% increase year-over-year.
- NATERA, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $35.15M, a 6.06% decline year-over-year.
- NATERA, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $33.56M, a 0.60% decline year-over-year.
- NATERA, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2017 was $135.51M, a 0.75% increase from fiscal 2016.
- NATERA, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2016 was $134.49M, a 19.18% increase from fiscal 2015.
- NATERA, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2015 was $112.84M, a 43.94% increase from fiscal 2014.
- NATERA, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2014 was $78.40M, a 110.32% increase from fiscal 2013.
| Period end | Cost of Goods Sold (Deprecated 2018-01-31) 3 month | Cost of Goods Sold (Deprecated 2018-01-31) 3 month as first filed | Cost of Goods Sold (Deprecated 2018-01-31) 6 month | Cost of Goods Sold (Deprecated 2018-01-31) 9 month | Cost of Goods Sold (Deprecated 2018-01-31) 9 month as first filed | Cost of Goods Sold (Deprecated 2018-01-31) 12 month | Cost of Goods Sold (Deprecated 2018-01-31) 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2018-06-30 | $39.20M 10-Q · filed 2018-08-09 | $78.26M 10-Q · filed 2018-08-09 | $113.41M derived: sum of 3 quarters · filed 2018-08-09 | $146.97M derived: sum of 4 quarters · filed 2018-08-09 | |||
| 2018-03-31 | $39.05M 10-Q · filed 2018-05-10 | $74.21M derived: sum of 2 quarters · filed 2018-05-10 | $107.77M derived: sum of 3 quarters · filed 2018-05-10 | $141.47M derived: sum of 4 quarters · filed 2018-08-09 | |||
| 2017-12-31 | $35.15M 10-K · filed 2018-03-15 | $68.71M derived: sum of 2 quarters · filed 2018-03-15 | $102.42M derived: sum of 3 quarters · filed 2018-08-09 | $135.51M 10-K · filed 2018-03-15 | |||
| 2017-09-30 | $33.56M 10-K · filed 2018-03-15 | $67.27M derived: sum of 2 quarters · filed 2018-08-09 | $100.36M 10-Q · filed 2017-11-09 | $137.78M derived: sum of 4 quarters · filed 2018-08-09 | |||
| 2017-06-30 | $33.71M 10-Q · filed 2018-08-09 | $66.80M 10-Q · filed 2018-08-09 | $104.22M derived: sum of 3 quarters · filed 2018-08-09 | $137.98M derived: sum of 4 quarters · filed 2018-08-09 | |||
| 2017-03-31 | $33.09M 10-Q · filed 2018-05-10 | $70.51M derived: sum of 2 quarters · filed 2018-05-10 | $104.27M derived: sum of 3 quarters · filed 2018-05-10 | $135.24M derived: sum of 4 quarters · filed 2018-05-10 | |||
| 2016-12-31 | $37.42M 10-K · filed 2018-03-15 | $38.00M 10-K · filed 2017-03-16 | $71.18M derived: sum of 2 quarters · filed 2018-03-15 | $102.15M derived: sum of 3 quarters · filed 2018-03-15 | $134.49M 10-K · filed 2018-03-15 | $135.57M 10-K · filed 2017-03-16 | |
| 2016-09-30 | $33.76M 10-K · filed 2018-03-15 | $34.26M 10-Q · filed 2016-11-14 | $64.73M derived: sum of 2 quarters · filed 2018-03-15 | $97.07M 10-Q · filed 2017-11-09 | $97.57M 10-Q · filed 2016-11-14 | $128.89M derived: sum of 4 quarters · filed 2018-03-15 | |
| 2016-06-30 | $30.97M 10-K · filed 2018-03-15 | $63.31M 10-Q · filed 2017-08-09 | $95.13M derived: sum of 3 quarters · filed 2018-03-15 | $125.58M derived: sum of 4 quarters · filed 2018-03-15 | |||
| 2016-03-31 | $32.34M 10-K · filed 2018-03-15 | $64.15M derived: sum of 2 quarters · filed 2018-03-15 | $94.61M derived: sum of 3 quarters · filed 2018-03-15 | $120.34M derived: sum of 4 quarters · filed 2018-03-15 | |||
| 2015-12-31 | $31.81M 10-K · filed 2017-03-16 | $62.27M derived: sum of 2 quarters · filed 2017-03-16 | $88.00M derived: sum of 3 quarters · filed 2017-03-16 | $112.84M 10-K · filed 2018-03-15 | |||
| 2015-09-30 | $30.46M 10-K · filed 2017-03-16 | $56.19M derived: sum of 2 quarters · filed 2017-03-16 | $81.03M 10-Q · filed 2016-11-14 | $103.69M derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2015-06-30 | $25.73M 10-K · filed 2017-03-16 | $50.58M 10-Q · filed 2016-08-11 | $73.24M derived: sum of 3 quarters · filed 2017-03-16 | $94.06M derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2015-03-31 | $24.84M 10-K · filed 2017-03-16 | $47.51M derived: sum of 2 quarters · filed 2017-03-16 | $68.33M derived: sum of 3 quarters · filed 2017-03-16 | $87.34M derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2014-12-31 | $22.66M 10-K · filed 2016-03-24 | $43.48M derived: sum of 2 quarters · filed 2016-03-24 | $62.50M derived: sum of 3 quarters · filed 2016-03-24 | $78.40M 10-K · filed 2017-03-16 | |||
| 2014-09-30 | $20.82M 10-K · filed 2016-03-24 | $39.83M derived: sum of 2 quarters · filed 2016-03-24 | $55.73M 10-Q · filed 2015-11-13 | ||||
| 2014-06-30 | $19.01M 10-K · filed 2016-03-24 | $34.91M 10-Q · filed 2015-08-13 | |||||
| 2014-03-31 | $15.90M 10-K · filed 2016-03-24 | ||||||
| 2013-12-31 | $37.27M 10-K · filed 2016-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |